Bob Burrows | VP, IR |
Dan Abdun Nabi | CEO |
Bob Kramer | President and COO |
Rich Lindahl | EVP, CFO and Treasurer |
Adam Havey | EVP, Business Operations |
Dana Flanders | Goldman Sachs |
Brandon Folkes | Cantor Fitzgerald & Co |
Yuko Oku | JPMorgan |
Keay Nakae | Chardan Capital Markets |
François Brisebois | Laidlaw |
Boris Peaker | Cowen and Company |
Lisa Springer | Singular Research |
Good day, ladies and gentlemen, and welcome to the Second Quarter 2018 Emergent BioSolutions Inc Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the call over to Robert Burrows, Vice President of Investor Relations.